Sanara MedTech Inc (NAS:SMTI)
$ 36.34 -0.22 (-0.6%) Market Cap: 317.65 Mil Enterprise Value: 333.30 Mil PE Ratio: 0 PB Ratio: 7.99 GF Score: 81/100

Sanara Medtech Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 05:30PM GMT
Release Date Price: $37.47 (+2.66%)
Zach Fleming
Sanara MedTech Inc. - CEO

All right. Small, intimate group here. Well, good to meet everybody. I am Zach Fleming. I am the CEO of Samara MedTech, traded on NASDAQ, SMTI. A little background on me: I came up through the wound care space, started in the wound care space, Healthpoint, and then got acquired by Smith & Nephew back in 2012 and then ran up through some leadership opportunities in Smith & Nephew, and then came here in 2017. It's been a really fun ride.

Before I get started, these are our disclaimers, [like most companies have their disclaimers]. All of these are statements that could have risks to them. We are based out of Fort Worth, Texas. We were a $303 million market cap as of November 25. In Q3 we generated 124% growth compared to the prior year.

And the way we are set up, we have two divisions: there is a surgical division, and it drives a lot of revenue for us today. It's a very big focus for us. And then in the future, we intend to do more around the comprehensive wound and skin spaces. And that's in the post-acute setting. That will launch fully

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot